Piperidine compounds for use as ccr-3 inhibitors
CA 2412941 C · Owner: Bhalay, Gurdip · Inventors: Le Grand, Darren Mark; Bhalay, Gurdip; Howe, Trevor John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formula (I) in free or salt form where Ar1 is phenyl substituted , by one or more halogen atoms Ar2 is phenyl or naphthyl which is unsubstituted or substituted by one or more substituents selected from halogen cyano, hydroxy, nitro, C1-C8-alkyl, C1-C8-haloalkyl C1-C8-alkoxy or C1-C8-, alkoxycarbonyl R1 is hydrogen or C1-C8-alkyl optionally substituted by hydroxy, C1-C8-alkoxy, acyloxy, N(R2)R3 halogen, carboxy, C1-C8-, alkoxycarbonyl -CON(R4)R5 or by a monovalent cyclic organic group R2 and R3 , are each independently hydrogen or C1-C8-alkyl or R2 is hydrogen and R3 is , acyl or -SO2R6 or R2 and R3 together with the nitrogen atom to which they are attached denote a 5- or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 10, 2001 and granted January 4, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 10, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 10, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.